Researchers at the University of Plymouth are leading an innovative initiative to advance the study of meningiomas in NF2-related schwannomatosis (NF2-SWN).

As we navigate the intricate maze of mesothelioma trials in California, it is essential to understand the legal landscape in play. From the collection of compelling evidence to the selection of expert ...

AbbVie announced positive topline results from its pivotal Phase III TEMPO-2 trial, evaluating tavapadon as a flexible-dose (5mg to 15mg, once daily) monotherapy in early Parkinson's disease (PD).

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the appointment of ...

Vitamin D regulates hormones, reduces menstrual pain, supports fetal development and preserves bone health during menopause.

In an official announcement the Russian Health Ministry said that a cancer vaccine will be launched in 2025 and will be ...

AI Powered Blood Test Detects Earliest Stage of Breast Cancer: Study FindsA new screening method that combines laser analysis ...

Drug discovery& development includes several processes and phases that demand a huge amount of funds ... drug optimization and repurposing, preclinical and clinical testing, and others), and end-user ...

The global artificial intelligence in clinical trials market is forecasted to grow steadily from US$1.20 billion in 2023 to ...

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

Danforth Advisors, LLC, today announced the acquisition of VPMR, LLC, a full-service, global market research firm serving ...